Prognostic value of differentiation status in gastric cancer
- PMID: 30176846
- PMCID: PMC6122741
- DOI: 10.1186/s12885-018-4780-0
Prognostic value of differentiation status in gastric cancer
Abstract
Background: Up to date, investigation of the prognostic value of differentiation status mainly focused on signet ring cell and mucinous gastric cancer. Thus, the present study aims to investigate the clinicopathological features and prognosis of gastric cancer patients with well, moderately and poorly differentiation status.
Methods: From September 2008 to March 2015, a total of 3090 gastric cancer patients treated with radical D2 gastrectomy were enrolled in the present study. Clinicopathological characteristics and prognosis of gastric cancer patients with well, moderately and poorly differentiation status were analyzed.
Results: There were 2422 male (78.4%) and 668 female (21.6%). The median age was 58 (20-90) years. There were 370 (12.0%) well differentiated tumors, 836 (27.0%) moderately differentiated tumors and 1884 (61.0%) poorly differentiated tumors. Well and moderately differentiation status were associated with older age, male gender, smaller tumor, shallower invasion, less lymph node involvement and earlier tumor stage (all p < 0.001). Inversely, poorly differentiation status was associated with younger age, female gender, larger tumor, deeper invasion, more lymph node involvement and later tumor stage (all p < 0.001). With respect to prognosis, well differentiation status was associated with favorable overall survival and poorly differentiation status was associated with unfavorable overall survival (p < 0.001). However, after matching with age, tumor size, T and N stage, there was no significant difference among the overall survival of the three groups (p = 0.415).
Conclusions: Well, moderately and poorly differentiation status was significantly associated with clinicopathological features of gastric cancer patients. However, it was not associated with the prognosis of gastric cancer patients.
Keywords: Clinicopathological characteristics; Differentiation status; Gastric cancer; Prognosis.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Ethics Committee of Xijing Hospital, and written informed consent was obtained from the patients in our center.
Consent for publication
Not applicable.
Competing interests
All of the authors declare that there are no financial or other relations that could lead to a conflict of interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
[Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):175-179. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 29492916 Chinese.
-
[Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):509-13. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24257302 Chinese.
-
Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.Endoscopy. 2009 Jun;41(6):498-503. doi: 10.1055/s-0029-1214758. Epub 2009 Jun 16. Endoscopy. 2009. PMID: 19533552
-
Biology of colorectal and gastric cancer cell lines.J Cell Biochem Suppl. 1996;24:131-41. doi: 10.1002/jcb.240630508. J Cell Biochem Suppl. 1996. PMID: 8806095 Review.
-
Prognostic factors for gastric cancer influencing clinical practice.World J Surg. 1995 Jul-Aug;19(4):496-500. doi: 10.1007/BF00294709. World J Surg. 1995. PMID: 7676690 Review.
Cited by
-
KLF5‑mediated expression of CARD11 promotes the progression of gastric cancer.Exp Ther Med. 2023 Jul 17;26(3):422. doi: 10.3892/etm.2023.12121. eCollection 2023 Sep. Exp Ther Med. 2023. PMID: 37602310 Free PMC article.
-
ISLR interacts with MGAT5 to promote the malignant progression of human gastric cancer AGS cells.Iran J Basic Med Sci. 2023;26(8):960-965. doi: 10.22038/IJBMS.2023.69372.15120. Iran J Basic Med Sci. 2023. PMID: 37427332 Free PMC article.
-
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy.Int J Clin Oncol. 2023 Sep;28(9):1158-1165. doi: 10.1007/s10147-023-02369-z. Epub 2023 Jun 15. Int J Clin Oncol. 2023. PMID: 37318644
-
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.Cancer Res Treat. 2023 Oct;55(4):1077-1086. doi: 10.4143/crt.2022.1630. Epub 2023 Jun 12. Cancer Res Treat. 2023. PMID: 37309112 Free PMC article.
-
Are radiomic spleen features useful for assessing the differentiation status of advanced gastric cancer?Front Oncol. 2023 May 5;13:1167602. doi: 10.3389/fonc.2023.1167602. eCollection 2023. Front Oncol. 2023. PMID: 37213311 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
